Nautilus Biotechnology Inc (NAUT)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.90-1.59%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · NAUT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 38.5 | 41.1 | 50.5 | 47.3 | 37.7 | 29.4 | 12.4 |
| Earnings from Continuing Operations | |||||||
| Other Non-Operating Income / Expenses | 6.3 | 7.8 | 10.7 | 12.5 | 5.7 | 0.2 | 0.1 |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (56.5) | (59.0) | (70.8) | (63.7) | (57.9) | (50.3) | (15.6) |
| Per Share | |||||||
| Basic EPS | (0.44) | (0.47) | (0.56) | (0.51) | (0.46) | (0.60) | (0.54) |
| Diluted EPS | (0.44) | (0.47) | (0.56) | (0.51) | (0.46) | (0.60) | (0.54) |
| Basic Weighted Avg Shares | 127.1 | 126.3 | 125.4 | 124.9 | 124.6 | 84.5 | 29.1 |
| Diluted Weighted Avg Shares | 127.1 | 126.3 | 125.4 | 124.9 | 124.6 | 84.5 | 29.1 |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.